A soft finish to 2024 still left stocks with a second straight stellar year. The S&P 500 logged a 23.3% gain, which follows a ...

U.S. stock indexes are starting 2025 with gains on Thursday. The S&P 500 rose 0.8% in morning trading and was on track to ...

Biotech giant Regeneron Pharmaceuticals (NASDAQ: REGN) started 2024 on a strong note and performed well through the first ...

Most Wall Street analysts see upside in the stock market in 2025. Here's what investors should know.

What can investors expect in 2025, as Trump's White House return hangs over Wall Street outlooks? Join our conversation ...

The estimated year-over-year S&P 500 earnings growth rate for 2025 hovers at 14.8 percent, according to FactSet. That’s well above the trailing 10-year average of eight percent, and the bump reflects ...

Over 700 key calls on the impact of Donald Trump’s return to the White House, the AI revolution, global political dysfunction ...

Alibaba to sell stake in China's hypermarket chain Sun Art. Brand prescription drugs to rise an average 4.5% in 2025.

The S&P 500 positioned itself on Thursday to snap a four-day losing streak that capped an otherwise strong 2024.

We recently published a list of Wall Street Is Focusing on These 10 AI Stocks as New Year Begins. In this article, we are ...